, /PRNewswire/ — VMS BioMarketing, a leading provider of patient engagement solutions, today announced its name change to Momentum Life Sciences. This strategic decision reflects the company’s profound impact on patients and its integral role within the evolving healthcare landscape.
The name change comes at a pivotal time for the biopharmaceutical industry, as companies increasingly prioritize patient engagement to enhance the patient experience and improve treatment outcomes.
Momentum Life Sciences will continue to build upon the legacy of VMS BioMarketing, leveraging its proven solutions and partnerships with leading pharmaceutical and biotech companies. The company has delivered over 10 million patient and healthcare provider (HCP) engagements across more than 100 specialty brands.
Momentum will continue to provide its core patient engagement, provider engagement and in-home care solutions, including the award-winning OneVoice™ solution. OneVoice™ integrates technology, advanced analytics, and behavioral science to deliver a tailored blend of human and digital interactions, providing data-driven, high-touch …